Mejias, M. P., Hiriart, Y., Lauché, C. E., Fernández Brando, R. J., Pardo, R. P., Bruballa, A. C., . . . Zylberman, V. (2016). Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS). Web
Citación estilo ChicagoMejias, María Pilar, et al. Development of Camelid Single Chain Antibodies against Shiga Toxin Type 2 (Stx2) With Therapeutic Potential against Hemolytic Uremic Syndrome (HUS). 2016.
Cita MLAMejias, María Pilar, et al. Development of Camelid Single Chain Antibodies against Shiga Toxin Type 2 (Stx2) With Therapeutic Potential against Hemolytic Uremic Syndrome (HUS). 2016.
Precaución: Estas citas no son 100% exactas.